These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 911241)
21. Tizanidine vs. baclofen in the treatment of spasticity in patients with multiple sclerosis. Rice GP Can J Neurol Sci; 1989 Nov; 16(4):451. PubMed ID: 2804809 [No Abstract] [Full Text] [Related]
22. Intrathecal baclofen for treatment of spasticity of multiple sclerosis patients. Ben Smail D; Peskine A; Roche N; Mailhan L; Thiébaut I; Bussel B Mult Scler; 2006 Feb; 12(1):101-3. PubMed ID: 16459726 [TBL] [Abstract][Full Text] [Related]
23. Effect of baclofen upon monosynaptic and tonic vibration reflexes in patients with spasticity. Mclellan DL; Maclellan DL J Neurol Neurosurg Psychiatry; 1973 Aug; 36(4):555-60. PubMed ID: 4269871 [TBL] [Abstract][Full Text] [Related]
24. Differences in effects in gamma and alpha spasticity induced by the GABA derivative baclofen (Lioresal). Knutsson E; Lindblom U; Mårtensson A Brain; 1973; 96(1):29-46. PubMed ID: 4266642 [No Abstract] [Full Text] [Related]
25. Tizanidine treatment of spasticity: a meta-analysis of controlled, double-blind, comparative studies with baclofen and diazepam. Groves L; Shellenberger MK; Davis CS Adv Ther; 1998; 15(4):241-51. PubMed ID: 10186943 [TBL] [Abstract][Full Text] [Related]
26. Intrathecal baclofen for muscle spasticity and pain--two case reports. Al Khudhairi D; Rababa A; Saddiqui MN Middle East J Anaesthesiol; 2006 Jun; 18(5):971-6. PubMed ID: 17094537 [No Abstract] [Full Text] [Related]
27. Double-blind comparison of single doses of DS103-282, baclofen and placebo for suppression of spasticity. Hassan N; McLellan DL J Neurol Neurosurg Psychiatry; 1980 Dec; 43(12):1132-6. PubMed ID: 7217960 [TBL] [Abstract][Full Text] [Related]
28. A review of the effects of baclofen and of THC:CBD oromucosal spray on spasticity-related walking impairment in multiple sclerosis. Arroyo González R Expert Rev Neurother; 2018 Oct; 18(10):785-791. PubMed ID: 30235965 [TBL] [Abstract][Full Text] [Related]
29. A double-blind comparative trial of new muscle relaxant, tizanidine (DS 103-282), and baclofen in the treatment of chronic spasticity in multiple sclerosis. Smolenski C; Muff S; Smolenski-Kautz S Curr Med Res Opin; 1981; 7(6):374-83. PubMed ID: 7016449 [TBL] [Abstract][Full Text] [Related]
32. Intrathecal baclofen therapy for spastic hypertonia. Ivanhoe CB; Tilton AH; Francisco GE Phys Med Rehabil Clin N Am; 2001 Nov; 12(4):923-38, viii-ix. PubMed ID: 11727722 [TBL] [Abstract][Full Text] [Related]
33. An approach to switching patients from baclofen to tizanidine. Brenner R; Hyman N; Knobler R; O'Brien M; Stephan T Hosp Med; 1998 Oct; 59(10):778-82. PubMed ID: 9850294 [TBL] [Abstract][Full Text] [Related]
34. Letter: Bacloffen in schizophrenia. Davis KL; Hollister LE; Berger PA Lancet; 1976 Jun; 1(7971):1245. PubMed ID: 58291 [No Abstract] [Full Text] [Related]
35. Intrathecal baclofen for spasticity in primary lateral sclerosis. Teive HA J Neurol; 2007 Feb; 254(2):261. PubMed ID: 17260176 [No Abstract] [Full Text] [Related]
36. Baclofen in the treatment of tardive dyskinesia. Nair NP; Yassa R; Ruiz-Navarro J; Schwartz G Am J Psychiatry; 1978 Dec; 135(12):1562-3. PubMed ID: 31097 [No Abstract] [Full Text] [Related]